APO Research, Inc.

APO RESEARCH · REPORT

Percutaneous Surgical System

Selected research

Market Outlook & Growth Opportunities

Global Percutaneous Surgical System Market Outlook and Growth Opportunities 2026

Market perspective

The global Percutaneous Surgical System market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Percutaneous Surgical System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Percutaneous Surgical System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Percutaneous Surgical System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Percutaneous Surgical System market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Percutaneous Surgical System market include Teleflex, Medtronic, B.Braun, Tuodao Medical and Grena Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Percutaneous Surgical System market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Percutaneous Surgical System and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Percutaneous Surgical System sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Percutaneous Surgical System market size, projected growth trends, production technologies, key applications, and end-use industries.

Percutaneous Surgical System Segment by Company

Teleflex

Medtronic

B.Braun

Tuodao Medical

Grena Ltd.

Percutaneous Surgical System Segment by Type

Percutaneous Needle Biopsy System

Percutaneous Catheter System

Others

Percutaneous Surgical System Segment by Application

Hospital

Clinic

Others

Percutaneous Surgical System Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Percutaneous Surgical System status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Percutaneous Surgical System market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Percutaneous Surgical System significant trends, drivers, influence factors in global and regions.

6. To analyze Percutaneous Surgical System competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Percutaneous Surgical System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Percutaneous Surgical System and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Percutaneous Surgical System.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Percutaneous Surgical System market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Percutaneous Surgical System industry.

Chapter 3: Detailed analysis of Percutaneous Surgical System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Percutaneous Surgical System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Percutaneous Surgical System in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Percutaneous Surgical System Industry Trends Table 2. Percutaneous Surgical System Industry Drivers Table 3. Percutaneous Surgical System Industry Opportunities and Challenges Table 4. Percutaneous Surgical System Industry Restraints Table 5. Global Percutaneous Surgical System Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Percutaneous Surgical System Revenue Share by Company (2021-2026) Table 7. Global Percutaneous Surgical System Sales Volume by Company (Units) & (2021-2026) Table 8. Global Percutaneous Surgical System Sales Volume Share by Company (2021-2026) Table 9. Global Percutaneous Surgical System Average Price (K US$/Unit) of Company (2021-2026) Table 10. Global Percutaneous Surgical System Company Ranking, (2024-2026) & (USD Million) Table 11. Global Percutaneous Surgical System Key Company Manufacturing Base & Headquarters Table 12. Global Percutaneous Surgical System Company, Product Type & Application Table 13. Global Percutaneous Surgical System Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Percutaneous Surgical System by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Percutaneous Needle Biopsy System Table 18. Significant Companies of Percutaneous Catheter System Table 19. Significant Companies of Others Table 20. Global Percutaneous Surgical System Sales Volume by Type 2021 VS 2025 VS 2032 (Units) Table 21. Global Percutaneous Surgical System Sales Volume by Type (2021-2026) & (Units) Table 22. Global Percutaneous Surgical System Sales Volume by Type (2027-2032) & (Units) Table 23. Global Percutaneous Surgical System Sales Volume Share by Type (2021-2026) Table 24. Global Percutaneous Surgical System Sales Volume Share by Type (2027-2032) Table 25. Global Percutaneous Surgical System Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Percutaneous Surgical System Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Percutaneous Surgical System Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Percutaneous Surgical System Sales Value Share by Type (2021-2026) Table 29. Global Percutaneous Surgical System Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital Table 31. Significant Companies of Clinic Table 32. Significant Companies of Others Table 33. Global Percutaneous Surgical System Sales Volume by Application 2021 VS 2025 VS 2032 (Units) Table 34. Global Percutaneous Surgical System Sales Volume by Application (2021-2026) & (Units) Table 35. Global Percutaneous Surgical System Sales Volume by Application (2027-2032) & (Units) Table 36. Global Percutaneous Surgical System Sales Volume Share by Application (2021-2026) Table 37. Global Percutaneous Surgical System Sales Volume Share by Application (2027-2032) Table 38. Global Percutaneous Surgical System Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Percutaneous Surgical System Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Percutaneous Surgical System Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Percutaneous Surgical System Sales Value Share by Application (2021-2026) Table 42. Global Percutaneous Surgical System Sales Value Share by Application (2027-2032) Table 43. Global Percutaneous Surgical System Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 44. Global Percutaneous Surgical System Sales by Region (2021-2026) & (Units) Table 45. Global Percutaneous Surgical System Sales Market Share by Region (2021-2026) Table 46. Global Percutaneous Surgical System Sales by Region (2027-2032) & (Units) Table 47. Global Percutaneous Surgical System Sales Market Share by Region (2027-2032) Table 48. Global Percutaneous Surgical System Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Percutaneous Surgical System Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Percutaneous Surgical System Sales Value Share by Region (2021-2026) Table 51. Global Percutaneous Surgical System Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Percutaneous Surgical System Sales Value Share by Region (2027-2032) Table 53. Global Percutaneous Surgical System Market Average Price (K US$/Unit) by Region (2021-2026) Table 54. Global Percutaneous Surgical System Market Average Price (K US$/Unit) by Region (2027-2032) Table 55. Global Percutaneous Surgical System Sales by Country: 2021 VS 2025 VS 2032 (Units) Table 56. Global Percutaneous Surgical System Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Percutaneous Surgical System Sales by Country (2021-2026) & (Units) Table 58. Global Percutaneous Surgical System Sales Market Share by Country (2021-2026) Table 59. Global Percutaneous Surgical System Sales by Country (2027-2032) & (Units) Table 60. Global Percutaneous Surgical System Sales Market Share by Country (2027-2032) Table 61. Global Percutaneous Surgical System Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Percutaneous Surgical System Sales Value Market Share by Country (2021-2026) Table 63. Global Percutaneous Surgical System Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Percutaneous Surgical System Sales Value Market Share by Country (2027-2032) Table 65. Teleflex Company Information Table 66. Teleflex Business Overview Table 67. Teleflex Percutaneous Surgical System Sales (Units), Value (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 68. Teleflex Percutaneous Surgical System Product Portfolio Table 69. Teleflex Recent Development Table 70. Medtronic Company Information Table 71. Medtronic Business Overview Table 72. Medtronic Percutaneous Surgical System Sales (Units), Value (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 73. Medtronic Percutaneous Surgical System Product Portfolio Table 74. Medtronic Recent Development Table 75. B.Braun Company Information Table 76. B.Braun Business Overview Table 77. B.Braun Percutaneous Surgical System Sales (Units), Value (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 78. B.Braun Percutaneous Surgical System Product Portfolio Table 79. B.Braun Recent Development Table 80. Tuodao Medical Company Information Table 81. Tuodao Medical Business Overview Table 82. Tuodao Medical Percutaneous Surgical System Sales (Units), Value (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 83. Tuodao Medical Percutaneous Surgical System Product Portfolio Table 84. Tuodao Medical Recent Development Table 85. Grena Ltd. Company Information Table 86. Grena Ltd. Business Overview Table 87. Grena Ltd. Percutaneous Surgical System Sales (Units), Value (US$ Million), Price (K US$/Unit) and Gross Margin (2021-2026) Table 88. Grena Ltd. Percutaneous Surgical System Product Portfolio Table 89. Grena Ltd. Recent Development Table 90. Key Raw Materials Table 91. Raw Materials Key Suppliers Table 92. Percutaneous Surgical System Distributors List Table 93. Percutaneous Surgical System Customers List Table 94. Research Programs/Design for This Report Table 95. Authors List of This Report Table 96. Secondary Sources Table 97. Primary Sources List of Figures Figure 1. Percutaneous Surgical System Product Image Figure 2. Global Percutaneous Surgical System Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Percutaneous Surgical System Sales Value (2021-2032) & (US$ Million) Figure 4. Global Percutaneous Surgical System Sales (2021-2032) & (Units) Figure 5. Global Percutaneous Surgical System Sales Average Price (K US$/Unit) & (2021-2032) Figure 6. Global Percutaneous Surgical System Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Percutaneous Needle Biopsy System Image Figure 10. Percutaneous Catheter System Image Figure 11. Others Image Figure 12. Global Percutaneous Surgical System Sales Volume by Type (2021 VS 2025 VS 2032) & (Units) Figure 13. Global Percutaneous Surgical System Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Percutaneous Surgical System Sales Volume Share by Type (2021-2032) Figure 15. Global Percutaneous Surgical System Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Percutaneous Surgical System Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Percutaneous Surgical System Sales Value Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Clinic Image Figure 20. Others Image Figure 21. Global Percutaneous Surgical System Sales Volume by Application (2021 VS 2025 VS 2032) & (Units) Figure 22. Global Percutaneous Surgical System Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Percutaneous Surgical System Sales Volume Share by Application (2021-2032) Figure 24. Global Percutaneous Surgical System Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Percutaneous Surgical System Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Percutaneous Surgical System Sales Value Share by Application (2021-2032) Figure 27. Global Percutaneous Surgical System Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 28. Global Percutaneous Surgical System Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Percutaneous Surgical System Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Percutaneous Surgical System Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Percutaneous Surgical System Sales Value (2021-2032) & (US$ Million) Figure 32. North America Percutaneous Surgical System Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Percutaneous Surgical System Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Percutaneous Surgical System Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Percutaneous Surgical System Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Percutaneous Surgical System Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Percutaneous Surgical System Sales Value (2021-2032) & (US$ Million) Figure 38. South America Percutaneous Surgical System Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Percutaneous Surgical System Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Percutaneous Surgical System Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Percutaneous Surgical System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Percutaneous Surgical System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Percutaneous Surgical System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Percutaneous Surgical System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Percutaneous Surgical System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Percutaneous Surgical System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Percutaneous Surgical System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Percutaneous Surgical System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Percutaneous Surgical System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Percutaneous Surgical System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Percutaneous Surgical System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Percutaneous Surgical System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Percutaneous Surgical System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Percutaneous Surgical System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Percutaneous Surgical System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Percutaneous Surgical System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Percutaneous Surgical System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Percutaneous Surgical System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Percutaneous Surgical System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Percutaneous Surgical System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Percutaneous Surgical System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Percutaneous Surgical System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Percutaneous Surgical System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Percutaneous Surgical System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Percutaneous Surgical System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Percutaneous Surgical System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Percutaneous Surgical System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Percutaneous Surgical System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Percutaneous Surgical System Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Percutaneous Surgical System Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Percutaneous Needle Biopsy System
  • Percutaneous Catheter System
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Teleflex
  • Medtronic
  • B.Braun
  • Tuodao Medical
  • Grena Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Percutaneous Surgical System Sales Value (2021-2032)
  4. 1.2.2 Global Percutaneous Surgical System Sales Volume (2021-2032)
  5. 1.2.3 Global Percutaneous Surgical System Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Percutaneous Surgical System Market Dynamics
  1. 2.1 Percutaneous Surgical System Industry Trends
  2. 2.2 Percutaneous Surgical System Industry Drivers
  3. 2.3 Percutaneous Surgical System Industry Opportunities and Challenges
  4. 2.4 Percutaneous Surgical System Industry Restraints
3 Percutaneous Surgical System Market by Company
  1. 3.1 Global Percutaneous Surgical System Company Revenue Ranking in 2025
  2. 3.2 Global Percutaneous Surgical System Revenue by Company (2021-2026)
  3. 3.3 Global Percutaneous Surgical System Sales Volume by Company (2021-2026)
  4. 3.4 Global Percutaneous Surgical System Average Price by Company (2021-2026)
  5. 3.5 Global Percutaneous Surgical System Company Ranking (2024-2026)
  6. 3.6 Global Percutaneous Surgical System Company Manufacturing Base and Headquarters
  7. 3.7 Global Percutaneous Surgical System Company Product Type and Application
  8. 3.8 Global Percutaneous Surgical System Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Percutaneous Surgical System Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Percutaneous Surgical System Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Percutaneous Surgical System Market by Type
  1. 4.1 Percutaneous Surgical System Type Introduction
  2. 4.1.1 Percutaneous Needle Biopsy System
  3. 4.1.2 Percutaneous Catheter System
  4. 4.1.3 Others
  5. 4.2 Global Percutaneous Surgical System Sales Volume by Type
  6. 4.2.1 Global Percutaneous Surgical System Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Percutaneous Surgical System Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Percutaneous Surgical System Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Percutaneous Surgical System Sales Value by Type
  10. 4.3.1 Global Percutaneous Surgical System Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Percutaneous Surgical System Sales Value by Type (2021-2032)
  12. 4.3.3 Global Percutaneous Surgical System Sales Value Share by Type (2021-2032)
5 Percutaneous Surgical System Market by Application
  1. 5.1 Percutaneous Surgical System Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Percutaneous Surgical System Sales Volume by Application
  6. 5.2.1 Global Percutaneous Surgical System Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Percutaneous Surgical System Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Percutaneous Surgical System Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Percutaneous Surgical System Sales Value by Application
  10. 5.3.1 Global Percutaneous Surgical System Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Percutaneous Surgical System Sales Value by Application (2021-2032)
  12. 5.3.3 Global Percutaneous Surgical System Sales Value Share by Application (2021-2032)
6 Percutaneous Surgical System Regional Sales and Value Analysis
  1. 6.1 Global Percutaneous Surgical System Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Percutaneous Surgical System Sales by Region (2021-2032)
  3. 6.2.1 Global Percutaneous Surgical System Sales by Region: 2021-2026
  4. 6.2.2 Global Percutaneous Surgical System Sales by Region (2027-2032)
  5. 6.3 Global Percutaneous Surgical System Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Percutaneous Surgical System Sales Value by Region (2021-2032)
  7. 6.4.1 Global Percutaneous Surgical System Sales Value by Region: 2021-2026
  8. 6.4.2 Global Percutaneous Surgical System Sales Value by Region (2027-2032)
  9. 6.5 Global Percutaneous Surgical System Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Percutaneous Surgical System Sales Value (2021-2032)
  12. 6.6.2 North America Percutaneous Surgical System Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Percutaneous Surgical System Sales Value (2021-2032)
  15. 6.7.2 Europe Percutaneous Surgical System Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Percutaneous Surgical System Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Percutaneous Surgical System Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Percutaneous Surgical System Sales Value (2021-2032)
  21. 6.9.2 South America Percutaneous Surgical System Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Percutaneous Surgical System Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Percutaneous Surgical System Sales Value Share by Country, 2025 VS 2032
7 Percutaneous Surgical System Country-level Sales and Value Analysis
  1. 7.1 Global Percutaneous Surgical System Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Percutaneous Surgical System Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Percutaneous Surgical System Sales by Country (2021-2032)
  4. 7.3.1 Global Percutaneous Surgical System Sales by Country (2021-2026)
  5. 7.3.2 Global Percutaneous Surgical System Sales by Country (2027-2032)
  6. 7.4 Global Percutaneous Surgical System Sales Value by Country (2021-2032)
  7. 7.4.1 Global Percutaneous Surgical System Sales Value by Country (2021-2026)
  8. 7.4.2 Global Percutaneous Surgical System Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Percutaneous Surgical System Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Percutaneous Surgical System Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Percutaneous Surgical System Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Percutaneous Surgical System Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Percutaneous Surgical System Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Percutaneous Surgical System Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Percutaneous Surgical System Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Percutaneous Surgical System Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Percutaneous Surgical System Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Percutaneous Surgical System Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Percutaneous Surgical System Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Percutaneous Surgical System Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Percutaneous Surgical System Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Percutaneous Surgical System Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Percutaneous Surgical System Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Percutaneous Surgical System Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Percutaneous Surgical System Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Percutaneous Surgical System Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Percutaneous Surgical System Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Percutaneous Surgical System Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Percutaneous Surgical System Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Percutaneous Surgical System Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Percutaneous Surgical System Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Percutaneous Surgical System Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Percutaneous Surgical System Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Percutaneous Surgical System Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Percutaneous Surgical System Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Percutaneous Surgical System Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Percutaneous Surgical System Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Percutaneous Surgical System Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teleflex
  2. 8.1.1 Teleflex Company Information
  3. 8.1.2 Teleflex Business Overview
  4. 8.1.3 Teleflex Percutaneous Surgical System Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Teleflex Percutaneous Surgical System Product Portfolio
  6. 8.1.5 Teleflex Recent Developments
  7. 8.2 Medtronic
  8. 8.2.1 Medtronic Company Information
  9. 8.2.2 Medtronic Business Overview
  10. 8.2.3 Medtronic Percutaneous Surgical System Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Medtronic Percutaneous Surgical System Product Portfolio
  12. 8.2.5 Medtronic Recent Developments
  13. 8.3 B.Braun
  14. 8.3.1 B.Braun Company Information
  15. 8.3.2 B.Braun Business Overview
  16. 8.3.3 B.Braun Percutaneous Surgical System Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 B.Braun Percutaneous Surgical System Product Portfolio
  18. 8.3.5 B.Braun Recent Developments
  19. 8.4 Tuodao Medical
  20. 8.4.1 Tuodao Medical Company Information
  21. 8.4.2 Tuodao Medical Business Overview
  22. 8.4.3 Tuodao Medical Percutaneous Surgical System Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Tuodao Medical Percutaneous Surgical System Product Portfolio
  24. 8.4.5 Tuodao Medical Recent Developments
  25. 8.5 Grena Ltd.
  26. 8.5.1 Grena Ltd. Company Information
  27. 8.5.2 Grena Ltd. Business Overview
  28. 8.5.3 Grena Ltd. Percutaneous Surgical System Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Grena Ltd. Percutaneous Surgical System Product Portfolio
  30. 8.5.5 Grena Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Percutaneous Surgical System Value Chain Analysis
  2. 9.1.1 Percutaneous Surgical System Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Percutaneous Surgical System Sales Mode & Process
  6. 9.2 Percutaneous Surgical System Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Percutaneous Surgical System Distributors
  9. 9.2.3 Percutaneous Surgical System Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.